Objectives: To review cardiovascular medication therapy during the Holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease and medication based on therapeutic class. The list of cardiovascular medications and switch from regular days to Ramadan days based on literature revealed that's included comparative safety studies, efficacy and cost of type of medication for each disease studies and national or international evidence-based guidelines of switching short half-life to long half-life. All parenteral dosage form of medication were excluded from this study. All medications should be listed in the Ministry of Health drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 studies were included for further evaluation. The evaluation revealed that there were 30 studies published on cardiovascular medications and Ramadan. Seven studies were further evaluated. The authors recommend to have a list of cardiovascular medications that can be switched from regular days to Ramadan days. Conclusion: There were very studies about cardiovascular medications use during the holy month of Ramadan. Suggested usage of the frequency administration single or twice daily is required during fasting. Future investigations of cardiovascular medication intake during Ramadan is highly recommended in Muslim countries.
INTRODUCTION
Cardiovascular disorders are one of the significant medical problems that is existing in the Kingdom of Saudi Arabia. 1 There are several diseases which the Saudi population is dealing with including but not limited to hypertension, coronary heart disease and lipid disorders; for each these disorders requires multiple medications to be administered to the patient. 1 The medications can be administered as a single dose or can be administered more frequently throughout the year. However, during the holy month of Ramadan, the administration of medications needs to adjust accordingly. Every year, all healthy Muslim population fast in the month of Ramadan; the individuals do not eat or drink or ingest any oral medications during fasting. The fast lasts for a duration of 10-15 h per day. It start from the sunrise until sunsets. Previous studies have shown that fasting does not negatively affect the cardiovascular disease except in the cases where the patient had a recent episode of myocardial infarction or acute coronary heart diseases. [2] [3] [4] In addition, the anticoagulation properties bleeding increase during the Ramadan. 4, 5 However, to best of our knowledge, there are no randomized clinical trials conducted to evaluate the effect of switching of medications from regular days to Ramadan days, for example, the switching of doses, frequency and time of administration. Moreover, there are no review studies regarding the use of cardiovascular medications during the holy month of Ramadan. Therefore, in this study, we aimed to review the literature regarding the use of cardiovascular medications during Ramadan and recommend the switching of medications from regular to Ramadan days based on the available literature. We included meta-analysis, randomized controlled studies and observational studies in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease and medication based on therapeutic class. The literature search on list of medications that can be switched from regular days to Ramadan days revealed that included comparative safety studies, efficacy and cost of type of medication for each disease studies and national or international evidence based guidelines of switching short half-life to long half-life. [6] [7] [8] The cardiovascular medication list included name of the drug, general dosing and frequency of administration during regular and Ramadan days. Oral medication under all patient-care settings such as inpatient, ambulatory care and community services were included in the search. All parenteral dosage form of medication were excluded from the study. All medications should be listed in the MOH drug formulary. The location of studies included were Saudi Arabia as the top priority, if not existed in Gulf or Middle Eastern countries; otherwise rest of the countries were included. If studies evidence not existed; the suggested came from author's experiences.
RESULTS
A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 were included for further evaluation. The evaluation revealed that 92 studies discussed about medications related to diabetes mellitus and Ramadan, 27 studies discussed the psychiatric medications and Ramadan, 27 studies investigated medications related to the gastrointestinal disorders and Ramadan, 30 studies discussed about the use of antibiotics and Ramadan, 30 studies discussed about the cardiovascular medications and Ramadan, 15 studies discussed about medicines for asthma and rheumatoid arthritis and Ramadan and 402 studies discussed other diseases and Ramadan. Finally, 7 studies were considered fit for further analysis. Among these, 3 studies discussed about the effect of INR coagulation indices. One retrospective study discussed about the anticoagulation therapy with doses and adverse effect which does not get affected by the fasting, whereas two observational studies discussed about the increase in the INR indices during fasting. One observational study discussed about the antihypertensive therapy during fasting and the other systematic review discussed about hypertension during fasting. Two systematic reviews discussed about acute cardiac diseases during fasting, whereas one review paper explored the medical disease affected by Ramadan (Table 1). We recommend the list of cardiovascular medications that can be switched from regular days to Ramadan days ( Table 2 ).
DISCUSSION
One of the pharmacy practice mentioned in the pharmacy strategic plan is RPC. 9, 10 This program takes care of medication-related issues in the holy month of Ramadan. One of the significant classes of medications is related to cardiovascular disease management, for example, diseases including hypertension, coronary heart disease, heart failure, coagulation disorders and lipid disorder. Fasting during the holy month of Ramadan will not affect the status of the disease except it changes the level of lipid in blood during the holy month of Ramadan. 3 In this study, the authors tried to formulate the switch protocol of medications from regular days to the Ramadan days based on the duration of action and frequency of administration. During fasting, once or twice administration is appreciated during the holy month of Ramadan. The authors tried to formulate the medications with multiple doses of frequency to switch to single or twice daily doses. The administration time should be changed to morning before sunrise and evening after sunset. The list suggests 85 medications based on their alphabetical order. All medications listed there are among those classes of medications that have a wide dosing range. The healthcare providers can refer to this list during Ramadan; the healthcare providers should review the approved indication with specific dose required. The switch therapy should be started before the holy month of Ramadan or at the beginning of the Ramadan. The patient should follow strict medication adherence during the holy month of Ramadan. Further clinical studies are highly recommended to validate the suggested schedule.
CONCLUSION
The cardiovascular medications intake may breakfast the holy month of Ramadan. Suggested the cardiovascular medication switch therapy from regular days to Ramadan days is highly recommended. All cardiovascular medication need submission individual studies about the medication during fasting during official country registration. Further studies of cardiovascular medication intake during the holy month of Ramadan is highly suggested in Muslim countries.
